Vertex Pharmaceuticals Ownership | Who Owns Vertex Pharmaceuticals?
Vertex Pharmaceuticals Ownership Summary
Vertex Pharmaceuticals is owned by 23.21% institutional investors, 0.15% insiders, and 76.64% retail investors. Capital world investors is the largest institutional shareholder, holding 10.09% of VRTX shares. American Funds Growth Fund of Amer A is the top mutual fund, with 4.72% of its assets in Vertex Pharmaceuticals shares.
VRTX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Vertex Pharmaceuticals | 23.21% | 0.15% | 76.64% |
| Sector | Healthcare Stocks | 42.64% | 10.86% | 46.50% |
| Industry | Biotech Stocks | 45.45% | 10.77% | 43.78% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Capital world investors | 25.91M | 10.09% | $10.15B |
| Vanguard group | 24.11M | 9.43% | $10.93B |
| Blackrock funding, inc. /de | 22.25M | 8.67% | $8.72B |
| Blackrock | 21.31M | 8.25% | $9.99B |
| Capital research global investors | 16.55M | 6.45% | $6.48B |
| State street | 11.61M | 4.52% | $4.55B |
| Jpmorgan chase | 6.43M | 2.51% | $2.52B |
| Geode capital management | 5.98M | 2.34% | $2.70B |
| Wellington management group llp | 4.77M | 1.86% | $1.87B |
| Capital investors | 4.69M | 1.83% | $1.84B |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Kynam capital management, lp | 330.00K | 11.93% | $154.68M |
| Provident investment management | 149.26K | 6.16% | $67.67M |
| Montchanin asset management | 10.74K | 4.76% | $5.03M |
| Andrew hill investment advisors | 12.41K | 4.28% | $5.63M |
| Bellevue group | 505.81K | 4.12% | $198.09M |
| Bridger management | 18.78K | 3.96% | $7.35M |
| Artia global partners lp | 55.10K | 3.42% | $21.58M |
| Healthinvest partners ab | 22.98K | 3.32% | $10.42M |
| Sectoral asset management | 8.01K | 2.91% | $3.63M |
| Birch hill investment advisors | 152.49K | 2.89% | $69.13M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Norges bank | 3.41M | 0.18% | 3.41M |
| Capital investors | 4.69M | 0.30% | 2.05M |
| Clearbridge investments | 2.65M | 0.78% | 1.12M |
| Jpmorgan chase | 6.43M | 0.15% | 565.42K |
| Capital research global investors | 16.55M | 1.22% | 444.99K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Fmr | 3.30M | 0.07% | -3.10M |
| Capital world investors | 25.91M | 1.39% | -2.82M |
| Parnassus investments | - | - | -1.65M |
| Edgewood management | 1.49M | 2.06% | -967.40K |
| Artisan partners limited partnership | - | - | -650.26K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Norges bank | 3.41M | 0.18% | 3.41M | $1.37B |
| Rakuten investment management | 242.46K | 0.09% | 242.46K | $24.14M |
| Axa investment managers | 163.68K | 0.17% | 163.68K | $64.10M |
| Sofinnova investments | 117.88K | 2.52% | 117.88K | $46.16M |
| Freestone grove partners lp | 110.28K | 0.32% | 110.28K | $43.19M |
Sold Out
| Holder | Change |
|---|---|
| Cgc financial services | -1.00 |
| Mine & arao wealth creation & management, llc. | -1.00 |
| Mcclarren financial advisors | -1.00 |
| Ruedi wealth management | -1.00 |
| Perkins coie trust | -1.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | 865 | -46.24% | 59,581,660 | -75.23% | 23 | 0.26% | 362 | -50.82% | 356 | -41.54% |
| Jun 30, 2025 | 1,575 | -5.06% | 240,147,012 | 1.70% | 93 | 1.11% | 716 | -14.86% | 599 | 4.90% |
| Mar 31, 2025 | 1,640 | 1.74% | 235,693,425 | -0.06% | 91 | 1.09% | 829 | 11.42% | 567 | -7.35% |
| Dec 31, 2024 | 1,444 | -9.69% | 218,148,736 | -5.74% | 84 | 1.05% | 664 | -9.78% | 543 | -5.89% |
| Sep 30, 2024 | 1,575 | -1.25% | 231,077,223 | -1.65% | 89 | 1.08% | 726 | -11.68% | 568 | 10.29% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| American Funds Growth Fund of Amer A | 12.13M | 4.72% | 790.12K |
| Capital Group Growth Fnd of Amer Comp | 12.13M | 4.72% | 790.12K |
| Vanguard US Total Market Shares ETF | 8.18M | 3.19% | 16.09K |
| Vanguard Total Stock Mkt Idx Inv | 8.07M | 3.15% | -186.29K |
| Vanguard Institutional 500 Index Trust | 7.30M | 2.84% | 51.91K |
| Vanguard 500 Index Investor | 6.36M | 2.48% | -931.08K |
| Invesco QQQ Trust | 5.29M | 2.06% | 36.76K |
| American Funds American Balanced A | 4.93M | 1.92% | - |
| Capital Group New Perspective Comp | 4.56M | 1.78% | 538.65K |
| American Funds New Perspective A | 4.56M | 1.78% | 538.65K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Feb 11, 2026 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | $214.56K |
| Feb 11, 2026 | Bunnage Mark E. | EVP, Chief Scientific Officer | Sell | $930.53K |
| Feb 11, 2026 | Biller Jonathan | EVP and Chief Legal Officer | Sell | $886.33K |
| Feb 11, 2026 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Sell | $806.21K |
| Feb 11, 2026 | Ambrose Kristen | SVP & Chief Accounting Officer | Sell | $633.55K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | - | 7 |
| 2025 Q4 | - | 23 |
| 2025 Q3 | 4 | 1 |
| 2025 Q2 | - | 2 |
| 2025 Q1 | - | 21 |
VRTX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools